Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Topical diclofenac sodium gel
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hand Osteoarthritis
1 trial -
Total glucosides of paeony & Acitretin Capsules
The First People's Hospital of Lianyungang
Psoriasis
1 trial -
Traditional Chinese Medicine treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Frail Elderly Patients
1 trial -
Tramadol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hip Fractures
1 trial -
Tranexamic acid (TXA)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Blood Loss
1 trial -
Transdermal nicotine patch
BRIGHT MINDS BIOSCIENCES INC.
Smoking
1 trial -
Transesophageal echocardiography
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Critically Ill
1 trial -
Treatment
United Therapeutics Europe Ltd
Glucose Metabolism Disorders
1 trial -
Trolamine (Biafine)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Radiation Dermatitis
1 trial -
Tumor Specific Antigen-loaded Dendritic Cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Tumor Gastric
1 trial -
UC-MSCs
Xiyuan Hospital of China Academy of Chinese Medical Sciences
2019 Novel Coronavirus Pneumonia
1 trial -
Ulinastatin and Thymosin Ξ±1
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Aortic Dissection
1 trial -
Unfractionated heparin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Primary PCI
1 trial -
Urapidil
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Aging
1 trial -
Usual care
Eye & ENT Hospital of Fudan University
Vestibular Disorder
1 trial -
Valerian
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Menopausal Women
1 trial -
Very low nicotine cigarettes
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Dependence
1 trial -
Village doctor-led tailored health management
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cardiovascular Diseases
1 trial -
Virtual Reality (VR) Contrast Function Test
Apellis Europe B.V.
Age-Related Macular Degeneration
1 trial -
Vitamin A
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Vitamin A Deficiency
1 trial -
Vitamin A
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Retinopathy of Prematurity
1 trial -
Vitamin D
The First People's Hospital of Lianyungang
Development, Child
1 trial -
Vitamin D and calcium
United Therapeutics Europe Ltd
Vitamin D Deficiency
1 trial -
Vitamin D3
Hospital Authority, Hong Kong
Major Depression
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources